Indivior PLC Faces Class Action Lawsuit
The Law Offices of Frank R. Cruz have reached out to investors about an upcoming deadline related to a significant class action lawsuit against Indivior PLC. This lawsuit is focused on the interests of those who acquired Indivior securities during a defined period.
Important Deadline for Investors
Investors should note that the deadline to file a lead plaintiff motion is rapidly approaching. Shareholders who faced losses due to investment in Indivior PLC are encouraged to understand their rights and the implications of this lawsuit.
Class Period and Stock Performance
The class period for this legal action is marked from February 22, 2024, to July 8, 2024. During this time, significant actions by Indivior have raised concerns among investors about the company's financial health and stock performance. Notably, on July 9, 2024, the company announced that it would cease all sales and marketing for its schizophrenia treatment, PERSERIS.
Impact on Indivior's Stock
This announcement had a dramatic effect on Indivior's stock price, which plummeted by $5.15, representing approximately a 33.6% drop, closing at $10.19 per share. Such changes can affect many investors and their decisions moving forward.
Allegations Against Indivior's Leadership
The allegations within the complaint assert that throughout the class period, the defendants provided materially misleading statements regarding the company's operations and financial prospects. Investors must be aware of these claims as they navigate their roles in the class action.
Key Points of Allegation
The lawsuit claims that there was a gross overstatement regarding Indivior's ability to predict the effects of certain legislation on its products, leading to unrealistic financial expectations. Furthermore, the management was accused of having misrepresented the prospects for key products including SUBLOCADE and PERSERIS.
Understanding Your Rights
If you have purchased Indivior shares during the specified class period, it is crucial to know the actions that you may take. The law firm encourages potential claimants to either appoint legal counsel or take a wait-and-see approach, allowing them to remain a part of the class without taking immediate action.
Get Informed and Take Action
For those affected, understanding the class action and your rights to participate is essential. You can reach out to the Law Offices of Frank R. Cruz for any inquiries regarding the procedure or your specific situation as an Indivior investor.
Contact Information for Legal Guidance
Investors in need of more information can contact Frank R. Cruz, located at 2121 Avenue of the Stars, Suite 800, Century City, California 90067, or by calling 310-914-5007. Alternatively, interested parties may send an email to info@frankcruzlaw.com to receive further assistance regarding this class action lawsuit.
Frequently Asked Questions
What is the deadline to file a lead plaintiff motion related to Indivior?
The deadline to file a lead plaintiff motion is October 1, 2024.
How did Indivior's stock react to the company's announcement?
Indivior's stock fell by $5.15, or 33.6%, closing at $10.19 per share after the announcement.
What are the key allegations against Indivior's management?
The key allegations include misleading statements about the financial impacts of legislation and exaggerated expectations for their products.
Can I still participate in the class action lawsuit?
Yes, investors can still participate and may choose to engage a lawyer or remain an absent member of the class.
Who can I contact for assistance regarding my rights as an investor?
You can contact Frank R. Cruz at the Law Offices of Frank R. Cruz for assistance and further information on your situation.